CryoPort (CYRX) CEO Shelton sold 150,000 shares for $1.01M at an average $6.72 under a 10b5-1 plan
Insider transactions reported
Jerrell Shelton (President, CEO at CryoPort Inc., CYRX) reported that they sold 150,000 shares for $1.01M at an average $6.72, and acquired 180,655 shares at $4.80 between Nov 18, 2024 and Nov 20, 2024. After these transactions the filing shows 722,747 shares held directly.
- Reporting person
- Shelton Jerrell
- Role
- President, CEO
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 18, 2024 | Exercise or conversion of a derivative (M) | Common Stock1 | +60,215 | $4.80 | $289K | 752,307 direct |
| Nov 18, 2024 | Open-market sale (S) | Common Stock1, 2 | -50,000 | $6.73 | $337K | 702,307 direct |
| Nov 19, 2024 | Exercise or conversion of a derivative (M) | Common Stock1 | +60,440 | $4.80 | $290K | 762,747 direct |
| Nov 19, 2024 | Open-market sale (S) | Common Stock1, 3 | -50,000 | $6.78 | $339K | 712,747 direct |
| Nov 20, 2024 | Exercise or conversion of a derivative (M) | Common Stock1 | +60,000 | $4.80 | $288K | 772,747 direct |
| Nov 20, 2024 | Open-market sale (S) | Common Stock1, 4 | -50,000 | $6.65 | $332K | 722,747 direct |
Options and other derivatives
| Date | Type | Security | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| Nov 18, 2024 | Exercise or conversion of a derivative (M) | Stock Option (right to buy)On 60,215 Common Stock1, 5 | -60,215 | - | - | 206,452 direct |
| Nov 19, 2024 | Exercise or conversion of a derivative (M) | Stock Option (right to buy)On 60,440 Common Stock1, 5 | -60,440 | - | - | 146,012 direct |
| Nov 20, 2024 | Exercise or conversion of a derivative (M) | Stock Option (right to buy)On 60,000 Common Stock1, 5 | -60,000 | - | - | 86,012 direct |
Holdings before and after
- Common Stock: 692,092 to 722,747 direct
- Stock Option (right to buy): 266,667 to 86,012 direct
Footnotes from the filing
- 1. The transactions reported in this Form 4 occurred automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 15, 2024.
- 2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.57 to $6.94, inclusive. The reporting person undertakes to provide to Cryoport, Inc., any security holder of Cryoport, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- 5. 1/48 of the options vested on the 18th of each month for forty-eight months beginning on January 18, 2015.
Transaction codes in this filing
- Open-market sale:
- Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
- Exercise or conversion of a derivative:
- Code M marks the exercise or conversion of an option or other derivative under an exempt plan.
FAQ
What did Shelton report in this CYRX Form 4?
Jerrell Shelton (President, CEO at CryoPort Inc., CYRX) reported that they sold 150,000 shares for $1.01M at an average $6.72, and acquired 180,655 shares at $4.80 between Nov 18, 2024 and Nov 20, 2024. After these transactions the filing shows 722,747 shares held directly.
How many CYRX shares does Shelton hold after this filing?
The filing shows 722,747 shares held directly after the reported transactions. Form 4 reports only the positions it lists, so this may not be every holding.
Was this CYRX insider sale made under a 10b5-1 plan?
The filing's footnotes mention a Rule 10b5-1 trading plan. Such a plan sets the terms of future trades in advance.
What does transaction code S mean on an SEC Form 4?
Code S marks a sale in the open market or a private deal. The insider received cash for these securities.
Historical context for CYRX
Earlier insider filings at CYRX
- Aug 26, 2024Director Hariri Robert J sold $9,465 worth of shares (1,000 units at $9.46), decreasing direct ownership by 4% to 23,061 units (SEC Form 4)
- Aug 20, 2024Director Hariri Robert J sold $17,395 worth of shares (2,000 units at $8.70), decreasing direct ownership by 8% to 23,561 units (SEC Form 4)
- Aug 7, 2024Director Mandalam Ramkumar exercised 4,167 shares at a strike of $5.04 and sold $33,520 worth of shares (4,167 units at $8.04) (SEC Form 4)
- May 21, 2024Mandalam Ramkumar was granted 12,845 shares, increasing direct ownership by 30% to 56,032 units (SEC Form 4)
- May 21, 2024Baddour Linda was granted 12,845 shares, increasing direct ownership by 59% to 34,535 units (SEC Form 4)
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
Follow CYRX and get a push notification the moment its next story breaks.